What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates?
Malaria caused by Plasmodium vivax continues being one of the most important infectious diseases around the world; P. vivax is the second most prevalent species and has the greatest geographic distribution. Developing an effective antimalarial vaccine is considered a relevant control strategy in the...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2017
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/24090
- Acceso en línea:
- https://doi.org/10.3389/fimmu.2017.00126
https://repository.urosario.edu.co/handle/10336/24090
- Palabra clave:
- Apical membrane antigen 1
Chemokine
Circumsporozoite protein
Duffy binding protein
Malaria vaccine
Merozoite surface protein 3
Merozoite surface protein 9
Protozoal protein
Recombinant protein
Synthetic peptide
Transcription factor
Unclassified drug
Adaptive immunity
Antigen binding
B lymphocyte
Cell invasion
Disease severity
Geographic distribution
Helper cell
Host cell
Human
Immune response
Immunological tolerance
Inflammation
Innate immunity
Macrophage activation
Minor histocompatibility complex
Natural killer cell
Neuromuscular blocking
Nonhuman
Pathogenesis
Phagolysosome
Plasmodium vivax malaria
Review
Serology
Sporozoite
T lymphocyte activation
Vaccine immunogenicity
Antigenicity
Immune response
Immunogenicity
Malaria
Plasmodium vivax
- Rights
- License
- Abierto (Texto Completo)
Summary: | Malaria caused by Plasmodium vivax continues being one of the most important infectious diseases around the world; P. vivax is the second most prevalent species and has the greatest geographic distribution. Developing an effective antimalarial vaccine is considered a relevant control strategy in the search for means of preventing the disease. Studying parasite-expressed proteins, which are essential in host cell invasion, has led to identifying the regions recognized by individuals who are naturally exposed to infection. Furthermore, immunogenicity studies have revealed that such regions can trigger a robust immune response that can inhibit sporozoite (hepatic stage) or merozoite (erythrocyte stage) invasion of a host cell and induce protection. This review provides a synthesis of the most important studies to date concerning the antigenicity and immunogenicity of both synthetic peptide and recombinant protein candidates for a vaccine against malaria produced by P. vivax. © 2017 López, Yepes-Pérez, Hincapié-Escobar, Díaz-Arévalo and Patarroyo. |
---|